Jupiter Wellness Advances Clinical Pipeline of CBD-Based Topical Treatments
Jupiter Wellness Advances Clinical Pipeline of CBD-Based Topical Treatments ACCESSWIRE Four Indications in Clinical Development JUPITER, FL / ACCESSWIRE / April 29, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a leading developer of cannabidiol (CBD) based medical therapeutics and wellness products, today announced an update on its clinical pipeline of CBD-based therapeutic topical formulations including JW-100 for the treatment of eczema, JW-200 for skin cancer, JW-300 for burns, and JW-400 for herpes cold sores. Commenced Patient Enrollment for Skin Cancer: Study Completion Expected Q4 202...
Source: phoenixherald.com